Archit Organosys Ltd will hold its 33rd Annual General Meeting (AGM) on Wednesday, September 30, 2026. The meeting will be conducted through video conferencing or other audio-visual means, with remote e-voting facilities available for shareholders.

Meeting Details

The company announced the meeting pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice was published in the Western Times newspaper on September 9, 2026.

Key Dates and Logistics

Shareholders holding shares in physical form can request login credentials by emailing share@architorg.com with their name, folio number, PAN, and Aadhaar card copies. Demat holders can request credentials via their depository participants or by emailing evoting@nsdl.co.in .

Voting and Record Dates

The company has appointed National Securities Depository Limited (NSDL) as the authorized agency for remote e-voting. The voting window will remain open for three days. Shareholders who vote remotely cannot vote again during the AGM.

The record date for determining dividend entitlements is Wednesday, September 23, 2026. The company’s share transfer books will remain closed from September 24, 2026, to September 29, 2026, inclusive.

What the Numbers Show

The announcement confirms the company’s adherence to regulatory timelines for its annual governance cycle. The decision to conduct the AGM virtually aligns with ongoing corporate practices for remote shareholder engagement, ensuring accessibility without requiring physical presence.

Archit Organosys reported a 59% year-on-year increase in net profit to ₹803.21 lakh for the fiscal year ended March 31, 2026, compared to ₹505.11 lakh in FY25.

The Ahmedabad-based specialty chemicals manufacturer saw total income rise by 11.77% to ₹14,383.71 lakh from ₹12,869.20 lakh in the previous fiscal. Revenue from operations specifically grew to ₹14,095.25 lakh from ₹12,559.92 lakh.

Financial Performance

Profit before tax reached ₹1,099.25 lakh, up significantly from ₹753.89 lakh in FY25. The company maintained steady operational costs while managing financial expenses effectively.

Financial expenses decreased to ₹228.82 lakh from ₹257.98 lakh, contributing to the improved bottom line. Depreciation and amortization expenses remained stable at ₹601.44 lakh.

Dividend Recommendation

The Board of Directors recommended a final dividend of ₹1 per equity share of face value ₹10 each for FY26, representing a 10% payout ratio. This is subject to shareholder approval at the 33rd Annual General Meeting scheduled for September 30, 2026.

What the Numbers Show

The divergence between revenue growth and profit expansion highlights improved operational leverage. While top-line growth stood at 11.77%, net profit surged nearly six times faster at 59%. This acceleration was supported by a reduction in financial expenses of ₹29.16 lakh and controlled operating costs, which grew at a slower pace than revenue. The effective tax rate also moderated to 26.93% from 33% in the previous year, further boosting bottom-line retention.

Corporate Governance Updates

Kandarp K. Amin retires by rotation at the upcoming AGM but offers himself for re-appointment as Chairman and Whole-Time Director. The meeting will also seek approval for related-party transactions with Archit Life Science Limited, including loans up to ₹75 crore and trade transactions up to ₹100 crore annually for FY27 and FY28.

The company plans to acquire a 67.44% stake in Archit Life Science Limited through a share swap arrangement, valuing the transaction at approximately ₹177.11 crore. This strategic move aims to strengthen its presence in the chemical industry through vertical integration.